A Textbook Transformation: How Biogen Idec Overhauled Its Supply Chain
May 02, 2011
Although strategic sourcing capabilities are well established in industries ranging from automotive to pharmaceuticals, they are still in the formative stages in the biotechnology sector.
It isn’t easy to drive the necessary changes. With their external spend increasing so fast, there is great pressure on biotech companies to rethink how their sourcing structures are set up to add most value. The first wave of strategic sourcing strategies is often targeted at cost-cutting through volume consolidation and leveraging of the organization’s total spend, followed by supplier base reduction and longer-term contracting. But as organizations mature, executives require their sourcing groups to develop and deliver additional capabilities. In a growing number of companies today, supply management is being asked to demonstrate deep insights into customer requirements, and to quickly translate those insights into product offerings that often rely more on outsourced capabilities.
Biogen Idec Inc. is showing how this can happen in the biotech sector. In the last year, the company has undergone a huge shift in the way it operates its supply chain, particularly in the management of sourcing.
![]() |
This complete article is available to subscribers
only. Click on Log In Now at the top of this article for full access. Or, Start your PLUS+ subscription for instant access. |
Not ready to subscribe, but need this article?
Buy the complete article now. Only $20.00. Instant PDF Download.
Access the complete issue of Supply Chain Management Review magazine featuring
this article including every word, chart and table exactly as it appeared in the magazine.
![]() |
Download Article PDF |
Although strategic sourcing capabilities are well established in industries ranging from automotive to pharmaceuticals, they are still in the formative stages in the biotechnology sector.
It isn’t easy to drive the necessary changes. With their external spend increasing so fast, there is great pressure on biotech companies to rethink how their sourcing structures are set up to add most value. The first wave of strategic sourcing strategies is often targeted at cost-cutting through volume consolidation and leveraging of the organization’s total spend, followed by supplier base reduction and longer-term contracting. But as organizations mature, executives require their sourcing groups to develop and deliver additional capabilities. In a growing number of companies today, supply management is being asked to demonstrate deep insights into customer requirements, and to quickly translate those insights into product offerings that often rely more on outsourced capabilities.
Biogen Idec Inc. is showing how this can happen in the biotech sector. In the last year, the company has undergone a huge shift in the way it operates its supply chain, particularly in the management of sourcing.
![]() |
SUBSCRIBERS: Click here to download PDF of the full article. |
Subscribe to Supply Chain Management Review magazine
Subscribe today. Don't miss out!
Get in-depth coverage from industry experts with proven techniques forcutting supply chain costs and case studies in supply chain best practices. Start Your Subscription Today!





Post a comment
Commenting is not available in this weblog entry.